Modulation of hedgehog-mediated signaling pathway
AssigneesThe Johns Hopkins University School of Medicine, Baylor College of Medicine
InventorsPhilip A. Beachy, Ming-Jer Tsai, Sophia Tsai, Venkatesh Krishnan, Chien-Huan Chen
Life of this patent
Estimating the term…
Abstract
The present invention provides transcription factors associated with the hedgehog signaling pathway that are regulated by dephosphorylation by phosphatases. Hedgehog response elements (HRE) that interact with the dephosphorylated transcription factors are also provided as well as methods for identifying compounds that are phosphatase inhibitors. Methods of treating tumors in a subject by modulating the phosphorylation of the transcription factor are also included.
Claims46
An isolated transcription factor involved in a hedgehog-mediated signaling pathway, said transcription factor comprising at least one phosphorylation site, wherein said transcription factor is dephosphorylated in response to said hedgehog mediated signaling pathway, and said transcription factor binds to a hedgehog response element.
A method for modulating expression of a target gene, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element, wherein said hedgehog response element is operatively associated with said target gene.
A method for modulating proliferation or differentiation of neuronal cells comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element operatively associated with a target gene, said target gene encoding a polypeptide that modulates proliferation or differentiation of neuronal cells.
A method for treating a cell proliferative disorder in a subject, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element by administering to the subject a modulating effective amount of a phosphatase inhibitor.
A method for inhibiting bone defects in a subject, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element operatively associated with a target gene, said target gene encoding a polypeptide involved in mediating bone development.
A method for diagnosing a hedgehog signaling pathway-mediated familial midline defect in a subject comprising determining the level of phosphorylated transcription factor as compared to the level of dephosphorylated transcription factor, wherein said transcription factor interacts with a hedgehog response element in response to said hedgehog signaling pathway;
- and correlating said level of phosphorylated transcription factor as compared to said level of dephosphorylated transcription factor with the susceptibility for a familial midline defect.
A method for identifying a compound that inhibits a phosphatase involved in a hedgehog signaling pathway comprising:
- a) incubating components comprising the compound, a transcription factor that binds to a hedgehog response element operatively associated with a target gene, and a phosphatase, under conditions sufficient to allow the components to interact;
- and
- b) measuring the ability of the compound to affect the hedgehog signaling pathway by detecting an increase or decrease in expression of the target gene.
A method for identifying a compound which affects a hedgehog signaling pathway comprising:
- a) incubating components comprising the compound, a phosphorylated transcription factor that binds to a hedgehog response element and a phosphatase, under conditions sufficient to allow the components to interact;
- and
- b) measuring the ability of the compound to affect hedgehog signaling pathway by detecting the phosphorylation state of the transcription factor in the presence and absence of the compound.
Dependencies are inferred from the claim text.